Stephen George Dilly
First SEC filing: June 18, 2026 · Latest: June 18, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 17, 2026 | CDXS | A | 66,350 | · | · | 66,350 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 11, 2025 | CDXS | A | 50,000 | $1.85 | $92,500 | 727,053 Direct | +7.38% | Acquired | -26.5% (price as of 2026-10-02) |
| Feb. 5, 2025 | CDXS | A | 532,500 | · | · | 532,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2025 | CDXS | A | 88,750 | · | · | 673,053 Direct | +15.19% | Acquired | (price as of 2026-10-02) |
| Jan. 1, 2024 | CDXS | A | 860,500 | · | · | 860,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 1, 2024 | CDXS | A | 143,425 | · | · | 582,303 Direct | +32.68% | Acquired | (price as of 2026-10-02) |
| Sept. 8, 2023 | CDXS | P | 58,479 | $1.73 | $101,169 | 438,878 Direct | +15.37% | Acquired | -21.4% (price as of 2026-10-02) |
| March 8, 2023 | CDXS | S | 26,987 | $4.56 | $123,061 | 380,399 Direct | -6.62% | Disposed | -70.2% (price as of 2026-10-02) |
| March 7, 2023 | CDXS | S | 28,088 | $4.60 | $129,205 | 407,386 Direct | -6.45% | Disposed | -70.4% (price as of 2026-10-02) |
| Feb. 21, 2023 | CDXS | A | 112,500 | · | · | 146,474 Direct | +331.14% | Acquired | (price as of 2026-10-02) |
| Feb. 21, 2023 | CDXS | A | 337,500 | · | · | 337,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 8, 2023 | CDXS | A | 289,000 | · | · | 435,474 Direct | +197.30% | Acquired | (price as of 2026-10-02) |
| Aug. 1, 2022 | CDXS | A | 700,000 | · | · | 700,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 14, 2022 | CDXS | A | 11,273 | · | · | 33,974 Direct | +49.66% | Acquired | (price as of 2026-10-02) |
| June 15, 2021 | CDXS | A | 4,796 | · | · | 22,701 Direct | +26.79% | Acquired | (price as of 2026-10-02) |
| June 16, 2020 | CDXS | A | 17,905 | · | · | 17,905 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 17, 2026 | CDXS | Stock Option (Right to Buy) | Common Stock | $2.48 | June 17, 2036 | 66,350 | Acquired |
| Feb. 5, 2025 | CDXS | Stock Option (Right to Buy) | Common Stock | $4.37 | Feb. 5, 2035 | 532,500 | Acquired |
| Jan. 1, 2024 | CDXS | Stock Option (Right to Buy) | Common Stock | $3.05 | Jan. 1, 2034 | 860,500 | Acquired |
| Feb. 21, 2023 | CDXS | Stock Option (Right to Buy) | Common Stock | $5.44 | Feb. 21, 2033 | 337,500 | Acquired |
| Aug. 1, 2022 | CDXS | Stock Option (Right to Buy) | Common Stock | $6.73 | Aug. 1, 2032 | 700,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $758,903 | · | · | · | $521,051 | · | $50,007 | $2,194,601 |
| 2024 | $713,550 | · | · | · | $535,163 | · | $53,800 | $3,472,920 |
| 2023 | $710,000 | · | · | · | $585,750 | · | $69,867 | $3,122,215 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.